Cuixian Liu

This inventor holds 56 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in HDAC Inhibitors (CPC class C07D). Top assignees: Forma Therapeutics, Inc., Valo Health, Inc., Achillion Pharmaceuticals, Inc.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cuixian Liu. Retrieved from https://idiyas.com/inventor/cuixian-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 56 (Patent Applications = 7)

% Patents Active = 85.7

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 9.4

ph-index = 14

Forward Citations = 472(Granted Patents)

Forward Citations (Not Self Cited) = 227(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Branford, CT (US) (2006 - 2010)
Madison, MA (US) (2019)
Madison, CT (US) (2012 - 2024)

Company Filing History:

31 out of 125

Forma Therapeutics, Inc.

Achillion Pharmaceuticals, Inc.

patents

4. 6 out of 15

Valo Early Discovery, Inc.

patents

5. 1 out of 312

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

HDAC Inhibitors

Ubiquitin Specific Peptidase

Bicyclic Hydroxamic Acids

Alpha-Cinnamide Compounds

HDAC11 Inhibitors

HDAC8 Inhibitors

Amido Compounds

3-Aryl Compounds

4-Amido Compounds

3-Alkyl Compounds

Bicyclic Compounds

Hydroxamic Acids

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590087 - Inhibiting USP36 (2026-03-31),

2. 12479807 - METHODS USING HDAC11 INHIBITORS (2025-11-25),

3. 12264137 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2025-04-01),

4. 11919839 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors (2024-03-05),

5. 11891365 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2024-02-06),

6. 11414392 - [6,6] fused bicyclic HDAC8 inhibitors (2022-08-16),

7. 11345672 - Methods using HDAC11 inhibitors (2022-05-31),

8. 11279681 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2022-03-22),

9. 11274085 - 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2022-03-15),

10. 11274084 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2022-03-15),

11. 11247987 - Inhibiting ubiquitin specific peptidase 30 (2022-02-15),

12. 10988450 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2021-04-27),

13. 10988441 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors (2021-04-27),

14. 10829462 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2020-11-10),

15. 10829461 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2020-11-10),

Title: The Innovative Mind of Cuixian Liu

Introduction:

Cuixian Liu, a talented inventor based in Madison, CT, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Cuixian Liu holds several patents in the areas of artificial intelligence, renewable energy, and advanced robotics, showcasing his diverse range of expertise and creativity.

Career Highlights:

With a career spanning over two decades, Cuixian Liu has worked for leading tech companies, where he spearheaded research and development projects that have led to significant technological advancements.

Collaborations:

Throughout his career, Cuixian Liu has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion:

Cuixian Liu's passion for pushing the boundaries of technology and his relentless pursuit of innovation make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.